MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1111/bpa.70092

Медицинская библиотека · Brain pathology (Zurich, Switzerland) · 2026

Molecular and clinical features of a Japanese medulloblastoma cohort: Subgroup-specific prognostic stratification using economical/accessible diagnostic methods.

Go Kohichi, Katsuma Asako, Yoshioka Ema, Shofuda Tomoko, Fukuoka Kohei, Ichimura Koichi, Matsushita Yuko, Mineharu Yohei, Makino Yasuhide, Kawauchi Takeshi, Sasaki Atsushi, Hirato Junko, Inoue Takeshi, Kodama Yoshinori, Mano Masayuki, Kanematsu Daisuke, Kijima Noriyuki, Kagawa Naoki, Keino Dai, Mukasa Akitake, Suzuki Tomonari, Yoshimoto Koji, Kuga Daisuke, Horiguchi Keishi, Yamaguchi Shigeru, Kanamori Masayuki, Yamasaki Kai, Ishibashi Kenichi, Akai Takuya, Yamaoka Masayoshi, Ishizaki Ryuji, Kawamura Atsufumi, Ohba Shigeo, Ishida Joji, Ando Ryo, Fukai Junya, Miwa Tomoru, Fujii Masazumi, Muroi Ai, Saito Kuniaki, Harada Atsuko, Hayashi Yasuhiko, Nonaka Masahiro, Park Young-Soo, Kobayashi Yusuke, Higuchi Tadashi, Miyairi Yosuke, Yoshifuji Kazuhisa, Takebe Noriyoshi, Oya Soichi, Nakajo Kosuke, Nakada Mitsutoshi, Nakano Yoshiteru, Kambara Mizuki, Adachi Koji, Tanaka Kazuhiro, Nakamura Hideo, Sonoda Yukihiko, Saito Ryuta, Wataya Takafumi, Kurozumi Kazuhiko, Taylor Michael D, Narita Yoshitaka, Shibui Soichiro, Arai Hajime, Sakamoto Hiroaki, Date Isao, Nagane Motoo, Nishikawa Ryo, Arakawa Yoshiki, Kanemura Yonehiro

СтатьяПеревод пока не подготовлен

Аннотация

Medulloblastoma (MB) is a biologically and clinically heterogeneous pediatric brain tumor. However, large-scale molecular subgrouping studies have mainly been conducted in Western populations, and comprehensive data from Asia are limited. To address this gap, we analyzed 242 MB cases collected from 39 institutions through the Japan Pediatric Molecular Neuro-Oncology Group, performing centralized molecular classification using NanoString-based gene expression profiling, DNA methylation arrays, and multiplex ligation-dependent probe amplification (MLPA)-based copy number profiling, supplemented by targeted sequencing. The subgroup distribution was 16.1% WNT, 24.8% SHH, 17.4% Group 3, and 41.7% Group 4. CTNNB1 mutations and monosomy 6 characterized all WNT cases, whereas MYCN amplification and TP53 mutations were independent adverse markers in SHH MB. Group 3 showed the worst survival, with MYC amplification and metastasis as poor prognostic factors. In Group 4, large cell/anaplastic histology predicted poor outcomes, whereas chromosome 11 loss was correlated with a favorable prognosis. Whole chromosomal aberration-defined favorable-risk patterns consistently indicate improved outcomes in non-WNT/non-SHH MBs. We also developed a simplified MLPA-based classifier targeting six loci on chromosomes 7, 8, and 11 (SEE-6-CNA), which enabled robust and clinically feasible prognostic stratification. Overall, our findings confirm that the molecular subgroup-specific features of Japanese MBs are largely concordant with global observations and that SEE-6-CNA provides a cost-effective tool to support individualized treatment planning, particularly in resource-limited settings.

Для цитирования: Go Kohichi, Katsuma Asako, Yoshioka Ema, Shofuda Tomoko, Fukuoka Kohei, Ichimura Koichi, Matsushita Yuko, Mineharu Yohei, Makino Yasuhide, Kawauchi Takeshi, Sasaki Atsushi, Hirato Junko, Inoue Takeshi, Kodama Yoshinori, Mano Masayuki, Kanematsu Daisuke, Kijima Noriyuki, Kagawa Naoki, Keino Dai, Mukasa Akitake, Suzuki Tomonari, Yoshimoto Koji, Kuga Daisuke, Horiguchi Keishi, Yamaguchi Shigeru, Kanamori Masayuki, Yamasaki Kai, Ishibashi Kenichi, Akai Takuya, Yamaoka Masayoshi, Ishizaki Ryuji, Kawamura Atsufumi, Ohba Shigeo, Ishida Joji, Ando Ryo, Fukai Junya, Miwa Tomoru, Fujii Masazumi, Muroi Ai, Saito Kuniaki, Harada Atsuko, Hayashi Yasuhiko, Nonaka Masahiro, Park Young-Soo, Kobayashi Yusuke, Higuchi Tadashi, Miyairi Yosuke, Yoshifuji Kazuhisa, Takebe Noriyoshi, Oya Soichi, Nakajo Kosuke, Nakada Mitsutoshi, Nakano Yoshiteru, Kambara Mizuki, Adachi Koji, Tanaka Kazuhiro, Nakamura Hideo, Sonoda Yukihiko, Saito Ryuta, Wataya Takafumi, Kurozumi Kazuhiko, Taylor Michael D, Narita Yoshitaka, Shibui Soichiro, Arai Hajime, Sakamoto Hiroaki, Date Isao, Nagane Motoo, Nishikawa Ryo, Arakawa Yoshiki, Kanemura Yonehiro. Molecular and clinical features of a Japanese medulloblastoma cohort: Subgroup-specific prognostic stratification using economical/accessible diagnostic methods.. Brain pathology (Zurich, Switzerland). 2026. DOI: 10.1111/bpa.70092.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.